A four-year argument, settled in two pages
On 9 November CMS published the final rule for the 2027 Medicare physician fee schedule: 1,029 pages in the Federal Register, effective 1 January. Somewhere past page 71163, under a heading numbered (7), the agency closed an argument that has been running since at least 2022, and closed it the way it has closed it before — by leaving both codes where they were.
HCPCS code G0277, “Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval,” survives. CPT code 99183, “Physician or other qualified health care professional attendance and supervision of hyperbaric oxygen therapy, per session,” stays separate. Medicare will continue to pay for a hyperbaric session as two things instead of one.
The operative sentence is flat, and worth quoting in full because it is the entire decision: “we continue to believe the existing coding structure, which distinguishes professional attendance and supervision (CPT code 99183) from treatment-delivery resources (HCPCS code G0277), remains appropriate and should be maintained.”
No oxygen, no pressure, no wound. A fee schedule resolves who is paid for what, and in hyperbaric medicine that question has an unusually literal shape: is a treatment session a medical service with a chamber attached, or a chamber service with a physician nearby? For another year, Medicare’s answer is that it is both, billed separately.
What the RUC actually asked for
The request came from the AMA/Specialty Society Relative Value Scale Update Committee, the panel that surveys physicians and recommends the relative values behind Medicare’s payment for professional services. As CMS records it, the RUC “has requested the deletion of HCPCS code G0277,” and recommended that CPT 99183 “be revised to be time-based as well to appropriately describe the treatment delivery, attendance and supervision.”
Its stated reason was administrative. Keeping a separate G-code, the committee concluded, “creates unnecessary coding complexity without adding clinical or administrative value and that one clear and consistent coding structure should exist for this service.” The mechanics were simple enough: take the January 2023 direct practice-expense inputs for G0277, crosswalk them into 99183, multiply by four, and treat the physician-attendance code as covering a full two-hour session.
Why four
Four is not arbitrary. In the 2023 fee schedule rule CMS described the service as it is actually delivered. “Hyperbaric oxygen therapy is typically administered to one patient in one hyperbaric chamber for 2 hours. Two hours is typical, and all inputs are prorated for four units being performed (each 30 minutes, totaling 2 hours).” One session, four billable half-hours.
Fold those four units into a single session code, and the chamber stops being a line item. Its operating cost becomes a component of a physician’s time — which is a different business, priced by a different survey, for a different set of providers.
Where the code came from
G0277 dates to 2015, and CMS has explained its parentage more than once, most fully in the 2024 rule. It was created “to describe direct practice expense inputs associated with CPT code 99183,” and specifically to align with the hospital side of Medicare, where the same half-hour was already reported under a separate treatment code, C1300, in the outpatient prospective payment system. The 2015 rule kept 99183 as the attendance code and, in CMS’s own quotation of it, “used the RUC recommended direct PE inputs for CPT code 99183 and adjusted them to align with the 30-minute treatment interval” (79 FR 67677).
So the two-code structure is not a fossil of coding history. It mirrors a decision that the box is a resource and the doctor is a professional service, and that both get paid on their own terms.
Medicare’s coverage policy makes the same assumption from the other direction. NCD 20.29, still served in the version effective 3 April 2017, opens its benefit categories with “Incident to a physician’s professional Service” and “Physicians’ Services,” and its coverage sentence is: “Program reimbursement for HBO therapy will be limited to that which is administered in a chamber (including the one man unit) and is limited to the following conditions.” Fifteen follow, from acute carbon monoxide intoxication to diabetic wounds of the lower extremities that meet three stated criteria.
The finding that started it: 10,000 and 100 percent
What put G0277 in front of the committee was not a clinical controversy but a screening rule. At its September 2022 Relativity Assessment Workgroup meeting, CMS wrote in the 2024 rule, the code “was identified as a high-volume growth code with Medicare utilization of 10,000 or more that have increased by at least 100 percent from 2015 through 2022 and was reviewed at the January 2023 RUC meeting.”
Those are thresholds, not totals, and they should be read as such. But they describe a code whose Medicare volume at least doubled in seven years and crossed the agency’s high-volume line — in a therapy that the same rule describes as typically delivered one patient at a time, in one chamber, for two hours.
The valuation record also caught two facts about the workforce that matter more than the coding question. “There was a change in the dominant specialty providing this service, which is now primarily performed by family medicine,” CMS wrote. And the staff mix changed too: where the valuation had assumed two people — “an RN/LPN/MA and an RN/respiratory therapist” — it now assumes one, “primarily due to a 2016 change by the National Board of Diving and Hyperbaric Medical Technology to no longer allow certified nursing assistants and certified medical assistants to be eligible to take the certified hyperbaric technologist examination.”
A certifying body’s eligibility rule, made in 2016, became an input in a federal price. Nobody planned that. It is what happens when a payment system measures a service closely enough to notice who is actually in the room.
The safety argument that set the price
The 2023 rule also records the one exchange in this fight where the argument was about patients rather than paperwork, and there the commenters beat CMS’s own proposal.
CMS had proposed trimming two preparatory tasks and, more consequentially, keeping 15 minutes of intra-service clinical labour per 30-minute unit, arguing that the RUC’s recommended 30 minutes rested on a “flawed assumption that the current 15 minutes for CA021 accounts for two patients receiving treatment simultaneously.”
The response it received is the clearest public statement of what attendance during hyperbaric therapy is supposed to mean. Commenters said the standard of practice is attendance and availability “for 100 percent of the time”; that “in a standard 2-hour session, which would account for four units of HCPCS code G0277, patients are at pressure for 106-110 minutes”; and that a total of 60 minutes of staff time “would not meet the standard of practice in which the clinical staff is in attendance for the entire treatment.”
CMS agreed, and said why. “We acknowledge that this time is needed to meet the standard of practice for clinical staff supervision during the entire treatment to ensure patient safety and to align with the time that patients are at pressure.” It finalized 30 minutes for the clinical labour activity and lifted the two equipment items to 38.25 minutes to match, since the chamber and the air-break breathing apparatus are in use for as long as someone is watching.
Then it drew the line that the 2027 rule would later defend: “We specify that clinical staff are supervised by physicians during the entirety of the treatment. Physician or QHP work is accounted for in CPT code 99183 … while HCPCS code G0277 solely accounts for practice expenses associated with hyperbaric oxygen therapy.”
Every element of that sentence is a payment category. But read alongside the FDA’s August 2025 letter to health care providers, which asks clinicians to “ensure the patient is properly monitored and supervised for the duration of the treatment,” it is also a description of the service.
What commenters said about the 2015 precedent
Two arguments carried the 2026 decision. The first was about what happened the last time the codes moved. “Several commenters stated that similar coding changes have previously caused Medicare and commercial payment disruption,” CMS wrote, “citing extended Medicare prepayment review and delayed commercial payer adoption following implementation of HCPCS code G0277 in 2015.”
The second was about who absorbs that disruption: “Commenters stated that this approach would also increase administrative burden for small, office-based practices.” Commenters also pointed out that the RUC had already sent 99183 to the CPT Editorial Panel for possible revision, and that converting it into a time-based code “would require either incorporating multiple 30-minute PE segments into CPT code 99183 or substantially redefining the code, neither of which has been adopted through the CPT process.”
CMS accepted all of it, then added a reason of its own that had nothing to do with clinical practice: deleting a high-volume code without an equivalent “can disrupt billing practices, create reporting gaps, and impose unnecessary administrative burden on providers who have integrated it into their standard practice.”
For 2027, the practical result is continuity in both directions. Hospital outpatient departments keep billing the half-hour as C1300; physician offices keep billing the session as 99183 plus up to four units of G0277. The fight is not settled, only deferred — the committee can return, and 99183 remains with the editorial panel.
What a surviving code does not decide
Three things sit outside a fee schedule, and hyperbaric medicine is a good place to be reminded of them.
The first is coverage. Keeping G0277 means the session can still be billed in two parts; it says nothing about which patients Medicare will pay for. NCD 20.29’s fifteen conditions are that list, and the same document carries an exclusion sentence as blunt as the coverage one: “No program payment may be made for any conditions other than those listed in §270.4(A).” Its non-covered list begins with “Cutaneous, decubitus, and stasis ulcers” and includes “Skin burns (thermal).” A code that pays for the chamber is not a coverage decision, and a coverage decision is not an evidence review.
The second is clearance. The FDA regulates devices, not claims: hyperbaric chambers are Class II devices cleared through the 510(k) process under product code CBF, and 21 CFR 868.5470 is the regulation that names them. In the letter dated 25 August 2025 the agency said it was “aware of recent reports of fires that occurred with HBOT devices that resulted in serious injuries and deaths,” that “the root cause of these events is not known,” and that it believes “serious adverse events associated with HBOT devices are rare,” while asking providers to ensure proper training, proper grounding, and supervision for the duration of treatment.
The third is evidence, and it is the one most easily lost in a coding story. Nothing in either fee schedule rule evaluates whether hyperbaric oxygen helps a given patient; the rules price attendance and equipment because those are the things a claims system can count. A service can be correctly coded, correctly paid, and still be the wrong treatment — which is why the coverage list, the clearance record and the trial literature remain three separate conversations, and why a billing code surviving a deletion request is news about accounting, not about medicine.
What the two codes encode, though, is not trivial. A hyperbaric session is a person watching and a machine running, and for at least another year Medicare is paying for both, separately, rather than pretending one is the other.
Sources
- Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule (final rule), 91 FR 70992
- Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule (proposed rule), 91 FR 43842
- Medicare and Medicaid Programs; CY 2024 Payment Policies Under the Physician Fee Schedule (final rule), 88 FR 78818
- CMS National Coverage Determination 20.29, Hyperbaric Oxygen Therapy
- FDA — Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices: Letter to Health Care Providers (25 August 2025)
- FDA product classification, Product Code CBF (chamber, hyperbaric), 21 CFR 868.5470
- 21 CFR 868.5470 — Hyperbaric chamber, electronic code of federal regulations